Skip to main content
Caplight Logo









Resolve Biosciences

Resolve Biosciences

Private
Monheim am RheinHealthcare & Life Scienceshttps://www.resolvebiosciences.com/

Last Round

Series B

Oct 24, 2022

Total Funding Raised

$95M

Company Overview

Resolve Biosciences is a biotechnology company that provides a molecular cartography platform for high-resolution spatial analysis of tissue architecture and cellular function.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

spatial biologyspatial transcriptomicssingle-cell analysismolecular cartographyspatial omicsgene expression analysistissue imagingbiotech servicesdrug discoveryoncology researchsingle-cell sequencingspatial profilinglife science toolslab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resolve Biosciences Comparables

Compare Resolve Biosciences with similar companies based on industry and business-model similarity.

Resolve Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vizgen
87%
Spatial Genomics
86%
Takara Bio Inc.
85%

Resolve Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 24, 2022
Series ADec 10, 2020

Key People

Founding team and executive leadership

John Stark

Chief Executive Officer

Executive Team

Peter Grünefeld

Chief Operating Officer

Executive Team

Marko Labus

Chief Financial Officer Executive Vice President

Executive Team

Resolve Biosciences Investors

Notable investors and investment history

Resolve Biosciences investors
InvestorRounds
PS Capital PartnersSeries A, Series B
Patient Square CapitalSeries B
EDBISeries B
MasterMind Transactions & Investment GmbHSeries A
NRW.BankSeries B
High-Tech GründerfondsSeries A
Alafi CapitalSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 24, 2022

    $71M round led by Patient Square Capital and PS Capital Partners.

  • Dec 10, 2020

    $24M round led by MasterMind Transactions & Investment GmbH and PS Capital Partners.

Resolve Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Resolve Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Resolve Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersMonheim am Rhein
Employee Range70
Year Founded2019
Last FundingOct 24, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?